N. Androulakis

927 total citations
29 papers, 721 citations indexed

About

N. Androulakis is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, N. Androulakis has authored 29 papers receiving a total of 721 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 15 papers in Pulmonary and Respiratory Medicine and 5 papers in Molecular Biology. Recurrent topics in N. Androulakis's work include Cancer Treatment and Pharmacology (17 papers), Colorectal Cancer Treatments and Studies (12 papers) and Lung Cancer Treatments and Mutations (12 papers). N. Androulakis is often cited by papers focused on Cancer Treatment and Pharmacology (17 papers), Colorectal Cancer Treatments and Studies (12 papers) and Lung Cancer Treatments and Mutations (12 papers). N. Androulakis collaborates with scholars based in Greece and France. N. Androulakis's co-authors include John Souglakos, D. Mavroudis, Ch. Kouroussis, George Samonis, L. Vamvakas, Vassilis Georgoulias, Stylianos Kakolyris, A. Kalykaki, K. Syrigos and A. Athanasiadis and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and British Journal of Cancer.

In The Last Decade

N. Androulakis

26 papers receiving 694 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
N. Androulakis Greece	14	638	326	191	122	94	29	721
Ernesto Durini Italy	7	629 1.0×	277 0.8×	222 1.2×	117 1.0×	88 0.9×	14	732
N. Vardakis Greece	17	629 1.0×	416 1.3×	108 0.6×	94 0.8×	163 1.7×	33	762
L. Vamvakas Greece	12	693 1.1×	351 1.1×	209 1.1×	102 0.8×	105 1.1×	48	807
Nicolas Moosmann Germany	12	449 0.7×	216 0.7×	107 0.6×	84 0.7×	45 0.5×	39	512
Samanta Cupini Italy	13	834 1.3×	278 0.9×	543 2.8×	200 1.6×	120 1.3×	35	956
Fritz Lang Austria	12	534 0.8×	240 0.7×	88 0.5×	187 1.5×	54 0.6×	16	640
Patrizia Trenta Italy	11	314 0.5×	229 0.7×	146 0.8×	98 0.8×	143 1.5×	21	535
Fabiola Lorena Rojas Llimpe Italy	10	500 0.8×	498 1.5×	57 0.3×	217 1.8×	117 1.2×	32	791
S D'Emidio Italy	8	452 0.7×	267 0.8×	90 0.5×	265 2.2×	162 1.7×	14	781
N. E. Kemeny United States	10	406 0.6×	131 0.4×	116 0.6×	221 1.8×	83 0.9×	24	521

Countries citing papers authored by N. Androulakis

Since Specialization

Citations

This map shows the geographic impact of N. Androulakis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Androulakis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Androulakis more than expected).

Fields of papers citing papers by N. Androulakis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Androulakis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Androulakis. The network helps show where N. Androulakis may publish in the future.

Co-authorship network of co-authors of N. Androulakis

This figure shows the co-authorship network connecting the top 25 collaborators of N. Androulakis. A scholar is included among the top collaborators of N. Androulakis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Androulakis. N. Androulakis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Souglakos, John, N. Vardakis, N. Androulakis, et al.. (2012). Irinotecan plus weekly 5-fluorouracil and leucovorin as salvage treatment for patients with metastatic colorectal cancer: A phase II trial.. PubMed. 10(1). 47–52.

Gioulbasanis, Ioannis, Zoe Giannousi, Emmanouil Saloustros, et al.. (2008). Prognostic value of Mini Nutritional Assessment (MNA) score in elderly lung-cancer patients. Critical Reviews in Oncology/Hematology. 68. S47–S47. 1 indexed citations

Souglakos, John, N. Androulakis, K. Syrigos, et al.. (2006). FOLFOXIRI (folinic acid, 5-fluorouracil, oxaliplatin and irinotecan) vs FOLFIRI (folinic acid, 5-fluorouracil and irinotecan) as first-line treatment in metastatic colorectal cancer (MCC): a multicentre randomised phase III trial from the Hellenic Oncology Research Group (HORG). British Journal of Cancer. 94(6). 798–805. 277 indexed citations

Souglakos, John, A. Kalykaki, L. Vamvakas, et al.. (2006). Phase II trial of capecitabine and oxaliplatin (CAPOX) plus cetuximab in patients with metastatic colorectal cancer who progressed after oxaliplatin-based chemotherapy. Annals of Oncology. 18(2). 305–310. 56 indexed citations

Souglakos, John, Athanasios Pallis, Stylianos Kakolyris, et al.. (2005). Combination of Irinotecan (CPT-11) plus 5-Fluorouracil and Leucovorin (FOLFIRI Regimen) as First Line Treatment for Elderly Patients with Metastatic Colorectal Cancer: A Phase II Trial. Oncology. 69(5). 384–390. 49 indexed citations

Georgoulias, Vassilis, Athina Agelidou, K. Syrigos, et al.. (2005). Second-line treatment with irinotecan plus cisplatin vs cisplatin of patients with advanced non-small-cell lung cancer pretreated with taxanes and gemcitabine: a multicenter randomised phase II study. British Journal of Cancer. 93(7). 763–769. 38 indexed citations

Mavroudis, D., Nikolaos Malamos, Aris Polyzos, et al.. (2004). Front-Line Chemotherapy with Docetaxel and Gemcitabine Administered Every Two Weeks in Patients with Metastatic Breast Cancer: A Multicenter Phase II Study. Oncology. 67(3-4). 250–256. 24 indexed citations

Mavroudis, D., A. Alexopoulos, Nikolaos Malamos, et al.. (2003). Salvage Treatment of Metastatic Breast Cancer with Docetaxel and Carboplatin. Oncology. 64(3). 207–212. 17 indexed citations

Pallis, Athanasios, D. Mavroudis, N. Androulakis, et al.. (2003). ZD1839, a novel, oral epidermal growth factor receptor-tyrosine kinase inhibitor, as salvage treatment in patients with advanced non-small cell lung cancer. Experience from a single center participating in a compassionate use program. Lung Cancer. 40(3). 301–307. 29 indexed citations

10.

Théodore, Christine, N. Androulakis, Alan Spatz, et al.. (2002). An explosive course of squamous cell penile cancer in an AIDS patient. Annals of Oncology. 13(3). 475–479. 15 indexed citations

11.

Mavroudis, D., M. Veslemes, F Apostolopoulou, et al.. (2002). Sequential administration of cisplatin–etoposide followed by topotecan in patients with extensive stage small cell lung cancer. A multicenter phase II study. Lung Cancer. 39(1). 71–76. 11 indexed citations

12.

Papakostas, Pavlos, Ch. Kouroussis, N. Androulakis, et al.. (2001). First-line chemotherapy with docetaxel for unresectable or metastatic carcinoma of the biliary tract. A multicentre phase II study. European Journal of Cancer. 37(15). 1833–1838. 40 indexed citations

13.

Kouroussis, Ch., John Souglakos, Stylianos Kakolyris, et al.. (2001). Oxaliplatin in Combination with Infusional 5-Fluorouracil and Leucovorin Every 2 Weeks as First-Line Treatment in Patients with Advanced Colorectal Cancer: A Phase II Study. Oncology. 61(1). 36–41. 16 indexed citations

14.

Agelaki, Sofia, A. Alexopoulos, Charalambos Kouroussis, et al.. (2001). Salvage treatment with irinotecan and gemcitabine in breast cancer patients pretreated with taxanes and anthracyclines: a multicenter phase II study. European Journal of Cancer. 37. S197–S198. 1 indexed citations

15.

Kakolyris, S., John Souglakos, Ch. Kouroussis, et al.. (2001). A Dose-Finding Study of Irinotecan (CPT-11) plus a Four-Day Continuous 5-Fluorouracil Infusion in Advanced Colorectal Cancer. Oncology. 60(3). 207–213. 5 indexed citations

16.

Kakolyris, S., Ch. Kouroussis, John Souglakos, et al.. (2001). A Phase I Clinical Trial of Topotecan Given Every 2 Weeks in Patients with Refractory Solid Tumors. Oncology. 61(4). 265–270. 4 indexed citations

17.

Kourousis, C., N. Androulakis, S. Kakolyris, et al.. (1998). First-line treatment of advanced nonsmall cell lung carcinoma with docetaxel and vinorelbine. Cancer. 83(10). 2083–2090. 37 indexed citations

18.

Kakolyris, S., Charalambos Kouroussis, John Souglakos, et al.. (1998). Phase I study of irinotecan (CPT-11) and cisplatin (CDDP) combination in metastatic non-small cell lung cancer (NSCLC). Lung Cancer. 21. S32–S32. 2 indexed citations

19.

Kourousis, C., S. Kakolyris, N. Androulakis, et al.. (1998). Salvage Chemotherapy With Paclitaxel, Vinorelbine, and Cisplatin (PVC) in Anthracycline-Resistant Advanced Breast Cancer. American Journal of Clinical Oncology. 21(3). 226–232. 18 indexed citations

20.

Kakolyris, Stylianos, C. Kourousis, N. Androulakis, et al.. (1997). Second line treatment of non-small cell lung cancer with paclitaxel and gemcitabine. European Journal of Cancer. 33. S232–S232. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact